Back to top

Ensysce Biosciences Seeks Extended Nasdaq Compliance Grace Period

Ensysce Biosciences ( ($ENSC) ) just unveiled an update. On August 5, 2026, Ensysce Biosciences acquired Cy Biopharma, Inc. and entered into a Secu...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: